1) Intrahepatic metastasis
肝内转移
1.
Two reasons for that includeintrahepatic metastasis (IM) and multiplecentric occurrence (MO).
研究目的 探讨多发肝癌在多中心发生和肝内转移方面的发病情况和鉴别两种类型肝癌的理想方法。
2.
Multiple and recurrent HCCs are mainly caused by intrahepatic metastasis (IM) known as developing from the same tumor or multicentric occurrence (MO) also known as multicentric carcinogenesis, which is independent from the primary tumor.
多结节性肝细胞癌和术后复发性肝细胞癌克隆起源方式可分为肝内转移(intrahepatic metastasis,IM)和多中心发生(multicentric occurrence,MO)两种情况,前者属于单克隆起源,而后者为多克隆起源。
3.
Multinolular and intrahepatic recurrent HCC can originate from intrahepatic metastasis and multiple origins,and their colnal origin is closely related to the clinical diagnosis and treatment.
多结节和复发性肝细胞癌可分为肝内转移和多中心发生两种,其克隆起源方式与临床诊治密切相关,根据其克隆起源方式设计合理的治疗方案是肝脏外科亟待解决的新问题。
2) liver metastasis
肝转移
1.
Effects of Shengmai injection combined with Oxaliplatin in treatment of liver metastasis from colon cancer;
生脉注射液联合奥沙利铂抗结肠癌肝转移的作用
2.
Relationships of VEGF and microvessel density with liver metastasis in human colorectal cancer;
VEGF和微血管密度与大肠癌肝转移的关系
3.
Proteomic analysis of differentially expressed proteins involved in primary focus and liver metastasis of human colorectal carcinomas;
结直肠癌原发灶及其肝转移灶的蛋白表达差异研究
3) Hepatic metastasis
肝转移癌
1.
Radical Operation of Colorectal Carcinoma Plus Radiofrequency Ablation for Hepatic Metastasis at Same Stage;
一期结直肠癌切除与射频消融治疗肝转移癌
4) hepatic metastasis
肝脏转移
1.
Expression of CDX2 protein and its significance in hepatic metastasis from colorectal carcinoma and primary hepatocellular carcinoma;
尾侧型同源转录因子-2在结直肠癌肝脏转移灶和原发性肝癌中的表达及意义
2.
Methods:The fresh specimens of primary cancer lesion and hepatic metastasis were collected in 5 patients suffered from colorectal cancer with liver metastasis during operation.
方法:收集手术切除5例大肠癌合并肝脏转移患者的原发和转移病灶的新鲜组织标本,提取总RNA,合成荧光标记的cRNA与Agilent human 1A oligo芯片杂交。
3.
The overexpression of MMP2 in normal liver tissues surrounding hepatic metastases might be correlated with the regeneration of hepatic metastasis.
目的:探讨MMP2基因在大肠癌肝脏转移中的意义。
5) hepatic metastasis
肝转移
1.
Effect of expression of COX-2, Ki-67 and MVD on hepatic metastasis of colorectal cancer;
大肠癌组织COX-2和Ki-67及MVD表达与肝转移相关性的研究
2.
Effect of percutaneous chemotherapy pump placement for portal vein chemotherapy on hepatic metastasis of colorectal cancer;
经皮化疗泵植入门静脉化疗治疗结直肠癌肝转移的临床观察
3.
The Effect of Syndrome on Tumor s Hepatic Metastasis;
血瘀状态下荷瘤小鼠肝转移的特点及相关机制研究
6) liver metastases
肝转移癌
1.
Objective To observe the performance of liver metastases with contrast-enhanced ultrasound(CEUS) and assess its clinical application.
目的观察肝转移癌超声造影表现并探讨其临床应用价值。
2.
Objective To observe the effects of percutaneous ethanol injection therapy (PEIT) for advanced liver metastases and to explore the dose of ethanol.
目的 观察无水酒精瘤内注射治疗肝转移癌的疗效 ,并探讨无水酒精的用量。
3.
Objective:To evaluate the feasibility and toxicity,and estimate the therapeutic effect of patients with unresectable liver metastases from colorectal carcinoma treated with three-dimensional conformal radiation therapy after TACE.
结论:对于结直肠癌根治术后出现不宜或不能手术的肝转移癌,应用三维适形放疗结合TACE的治疗模式,是可行的,无严重不良反应,近期疗效显著。
补充资料：正常人白细胞转移因子 , 白细胞转移因子,转移因子
药物名称：转移因子
英文名：Transfer Factor
别名： 正常人白细胞转移因子 , 白细胞转移因子,转移因子
外文名：Transfer Factor ,TF
适应症： 为细胞免疫反应增强剂，能将细胞免疫活性转移给受体，以提高受体的免疫功能。
临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染（如带状皰疹、流行性乙型脑炎、白色念珠菌感染等）。对恶性肿瘤可作为辅助治疗剂，对自体免疫性疾病也有一定治疗作用。
用量用法：
一般采用皮下注射，注于上臂内侧或大腿内侧腹股沟下端，１次注射１支，每周１～２次，１个月后改为每２周１次。对带状疱疹，一般只需注射１次。
规格： 注射液：每支２ｍｌ，相当于１×１０００００００００白细胞提取物（上海产）,北京产则相当于５～１０×1000000000.
注：严禁静脉给药.
类别：免疫调节剂
英文名：Transfer Factor
别名： 正常人白细胞转移因子 , 白细胞转移因子,转移因子
外文名：Transfer Factor ,TF
适应症： 为细胞免疫反应增强剂，能将细胞免疫活性转移给受体，以提高受体的免疫功能。
临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染（如带状皰疹、流行性乙型脑炎、白色念珠菌感染等）。对恶性肿瘤可作为辅助治疗剂，对自体免疫性疾病也有一定治疗作用。
用量用法：
一般采用皮下注射，注于上臂内侧或大腿内侧腹股沟下端，１次注射１支，每周１～２次，１个月后改为每２周１次。对带状疱疹，一般只需注射１次。
规格： 注射液：每支２ｍｌ，相当于１×１０００００００００白细胞提取物（上海产）,北京产则相当于５～１０×1000000000.
注：严禁静脉给药.
类别：免疫调节剂
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条